newsfilter
← Latest News
GlobeNewswire·

Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors

BALA CYNWYD, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today